Stock Traders Buy High Volume of Call Options on ASP Isotopes (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) was the recipient of unusually large options trading on Tuesday. Stock investors purchased 3,973 call options on the company. This is an increase of 33% compared to the average volume of 2,994 call options.

ASP Isotopes Stock Performance

ASPI opened at $7.00 on Wednesday. ASP Isotopes has a twelve month low of $1.86 and a twelve month high of $9.33. The firm has a market capitalization of $525.43 million, a PE ratio of -11.48 and a beta of 3.40. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. The firm’s 50-day moving average price is $5.34 and its 200 day moving average price is $5.44.

Insider Transactions at ASP Isotopes

In other ASP Isotopes news, CEO Paul Elliot Mann sold 316,667 shares of the firm’s stock in a transaction on Tuesday, April 15th. The stock was sold at an average price of $5.75, for a total value of $1,820,835.25. Following the transaction, the chief executive officer now owns 7,948,787 shares in the company, valued at approximately $45,705,525.25. This trade represents a 3.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Robert Ainscow sold 66,668 shares of ASP Isotopes stock in a transaction on Thursday, April 17th. The stock was sold at an average price of $5.62, for a total transaction of $374,674.16. Following the sale, the chief operating officer now directly owns 1,419,992 shares in the company, valued at approximately $7,980,355.04. This trade represents a 4.48% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 766,667 shares of company stock valued at $4,358,502 over the last ninety days. Insiders own 21.40% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Hanson & Doremus Investment Management acquired a new stake in shares of ASP Isotopes in the fourth quarter valued at approximately $27,000. BNP Paribas Financial Markets purchased a new stake in ASP Isotopes in the 4th quarter valued at $34,000. SBI Securities Co. Ltd. increased its stake in shares of ASP Isotopes by 84.8% in the 1st quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company’s stock worth $44,000 after acquiring an additional 4,299 shares during the last quarter. Avantax Advisory Services Inc. purchased a new position in shares of ASP Isotopes during the 4th quarter worth $45,000. Finally, Russell Investments Group Ltd. boosted its position in shares of ASP Isotopes by 56.3% during the 4th quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company’s stock valued at $46,000 after acquiring an additional 3,682 shares during the last quarter. 16.80% of the stock is currently owned by institutional investors and hedge funds.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.